Eurobio Scientific logo

Eurobio Scientific

DXNHF · OTC · Diagnostics and Testing, Biotech · Founded 1997

Eurobio-Scientific SA provides in vitro diagnostics solutions. It engages in designing, development and commercialization of tests diagnosis in the fields of transplantation, infectious diseases, autoimmunity and oncology, as well as products for research in the field of life sciences.

Current Price
—
Market Cap
$290M
Return Since Last Split
—
Last Split
Dec 19, 2012
Total Splits
1
Cumulative Multiple
2×

What If You Bought DXNHF Earlier?

Investment
Purchase Date (Before Split)
Worth Today
—
200 shares · 2×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Dec 19, 2012—2-for-12×2×

Eurobio Scientific Market Cap Timeline

Validated annual market-cap history is available from 2006. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Frequently Asked Questions

Eurobio Scientific's latest record in the split calendar is a 2-for-1 forward split effective 2012-12-19.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.